Dr. Kipps is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr
# Mail
La Jolla, CA 92093Phone+1 858-534-5400Fax+1 858-534-5620
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1982 - 1984- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1979 - 1981
Harvard Medical SchoolClass of 1979
Certifications & Licensure
CA State Medical License 1980 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:San Diego Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia Start of enrollment: 2006 Jan 01
- A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) Start of enrollment: 2006 Mar 01
- Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) Start of enrollment: 2008 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 3509 citationsFrequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemiaGeorge A. Calin, Calin Dan Dumitru, Masayoshi Shimizu, Roberta Bichi, Simona Zupo
Proceedings of the National Academy of Sciences of the United States of America. 2002-11-26 - 149 citationsRelationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosineHajime Kawasaki, Carlos J. Carrera, Lawrence D. Piro, Alan Saven, Thomas J. Kipps
Blood. 1993-02-01 - 198 citationsImportance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.Thomas J. Kipps, Peter Parham, J Punt, L A Herzenberg
The Journal of Experimental Medicine. 1985-01-01
Journal Articles
- SET Alpha and SET Beta mRNA Isoforms in Chronic Lymphocytic LeukaemiaDanielle M Brander, J Brice Weinberg, Daphne R Friedman, Thomas J Kipps, British Journal of Haematology
- Sustained Efficacy and Detailed Clinical Follow-up of First-Line Ibrutinib Treatment in Older Patients with Chronic Lymphocytic Leukemia: Extended Phase 3 Results from...Steven Coutre, Thomas J Kipps, Jan A Burger, Nancy L Bartlett, Paul M Barr, Haematologica
- MiR-125a and MiR-34a Expression Predicts Richter Syndrome in Chronic Lymphocytic Leukemia PatientsThomas J Kipps, John A Thorson, Blood
Abstracts/Posters
- Four-Year Analysis of Murano Study Confirms Sustained Benefit of Time-Limited Venetoclax-Rituximab (VenR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)Thomas J. Kipps, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Rapid Undetectable MRD (uMRD) Responses in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Lisoc...Thomas J. Kipps, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High-Level ROR1 and BCL2, Cancer-Stemness, and BCL2 Mutations Associate with Venetoclax Resistance in Chronic Lymphocytic LeukemiaThomas J. Kipps, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Approaches to Personalized Treatment for CLL: Expert Guidance on Sequencing Therapy and Novel Agents61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Ibrutinib Reduces Obinutuzumab-Gazyva Infusion Related Reactions (IRR) in Patients with Chronic Lymphocytic Leukemia (CLL) and It Is Associated with Changes on Plasma ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Durability of Responses on Continuous Therapy and Following Drug Cessation in Deep Responders with Venetoclax and Rituximab2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Scientists Map Genetic Evolution of Chronic Lymphocytic Leukemia to Richter’s SyndromeDecember 11th, 2022- What's on Tap at the Society of Hematologic Oncology's 10th Annual MeetingSeptember 26th, 2022
- Oncternal Therapeutics : Lee 2022 ASCO Poster Zilovertamab + Ibrutinib for MCL and CLLJune 7th, 2022
- Join now to see all
Grant Support
- Specialized Cancer Center Support GrantNational Cancer Institute2011
- Chronic Lymphocytic Leukemia Research ConsortiumNational Cancer Institute2000–2011
- Antibody V Gene Expression B Cell Lymphocytic LeukemiaNational Cancer Institute1999–2011
- Lenalidomide Treatment And The Chronic Lymphocytic Leukemia MicroenvironmentNational Cancer Institute2009–2010
- Active Immune Therapy OT Leukemia Associated Antigens And Gene TherapyNational Cancer Institute2006–2010
- Tumor Therapy/Annihilation Using A Smart Nanoplatform (SNAP)National Cancer Institute2005–2009
- A CRC Phase 1 Study Of Clofarabine For Treatment Of Relapsed/Refractory CLLNational Center For Research Resources2006
- Administrative CoreNational Cancer Institute2006
- Phase I/II Study Of Xcellerated T Cells In Chronic Lymphocytic LeukemiaNational Center For Research Resources2005–2006
- Immune Monitoring In B Cell CLL Patients Treated With Ad-Cd154 CellsNational Center For Research Resources2005
- Gx15-070ms Every 3 Weeks For Refractory Chronic Lymphocytic LeukemiaNational Center For Research Resources2005
- Phase I/II Study Of Xcellerated T Cells In CLLNational Center For Research Resources2004
- Immune Monitoring In B Cell CLL Treated With Ad-Cd154National Center For Research Resources2004
- Competing Supplement For CLL Research ConsortiumNational Cancer Institute2003
- Translational OncologyNational Cancer Institute2001–2002
- Gene Transfer Of CD154 Into Myeloma Plasma CellsNational Center For Research Resources2000–2002
- Autoimmune Hemolytic Anemia And Expression Of IG GenesNational Center For Research Resources2000–2002
- Immunology Of CLL I--Acitive ImmunotherapyNational Cancer Institute2000–2002
- Phase I Study Of CD40 Ligand Transduced Leukemia Cells In CLLNational Center For Research Resources1999–2002
- Synovium As An Immune Underprivileged SiteNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2002
- Erb 2neu DNA Vaccines For Breast Cancer ImmunotherapyNational Cancer Institute1998–2002
- Core--Flow Cytometry FacilityNational Cancer Institute1994–2002
- Translational Oncology--Pathogenesis, Prognosis And Genetic SusceptibilityNational Cancer Institute2000
- Immunology Of CLL I--Active Immunotherapy &Autologous Stem Cell TransplantationNational Cancer Institute1999
- Chronic Lymphocytic Leukemia Research ConsortiumNational Cancer Institute1999
- Regulation Of CD40L On Lymphocytes In Systemic Lupus ErythematosusNational Center For Research Resources1998–1999
- Antibody V Gene Expression In B Cell CLLNational Cancer Institute1994–1998
- Immunoglobulin And Gene ExpressionNational Center For Research Resources1996–1997
- Effect Of N-Acetylcysteine On Lymphocyte Activation In Rheumatoid ArthritisNational Center For Research Resources1996–1997
- ERBB 2/Neu DNA Vaccines For Breast Cancer ImmunotherapyNational Cancer Institute1996–1997
- Erbb-2/Neu DNA Vaccines For Breast Cancer ImmunotherapyNational Cancer Institute1995–1997
- Immunobiology Of AIDS LymphomasNational Cancer Institute1994–1997
- Immunologic Aging And AutoimmunityNational Institute On Aging1992–1994
- Mechanisms Of Aids-Associated LymphomagenesisNational Cancer Institute1991–1994
- New Modalities For Active Immunotherapy Of MalignanciesNational Cancer Institute1992–1993
- Novel Therapeutic Approaches In Hiv-Associated LymphomasNational Cancer Institute1991–1993
- Antibody V Gene Expression In Human B Cell MalignanciesNational Cancer Institute1990–1993
- Immunologic Aging And AutoimmunityNational Institute On Aging1991
- Human Antibody Diversity In Health &AutoimmunityNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1990
- Antibody V Gene Expression In Human B Cell MalignanciesNational Cancer Institute1989–1990
- Isolation And Function Of Switch Variant Monoclonal AntibodiesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1989
- Bone Marrow In Immunologic Aging And AutoimmunityNational Institute On Aging1987–1989
- Human Antibody Diversity In Health &AutoimmunityNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986–1989
- Multiparameter Fluorescence Activated Cell SorterNational Center For Research Resources1988
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
